Fate Therapeutics
FATE
FATE
180 hedge funds and large institutions have $642M invested in Fate Therapeutics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 73 increasing their positions, 54 reducing their positions, and 67 closing their positions.
Holders
180
Holders Change
-47
Holders Change %
-20.7%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
73
Reduced
54
Closed
67
Calls
$247K
Puts
$368K
Net Calls
-$121K
Net Calls Change
-$203K
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$84.5M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$62.5M |
3 |
3
D.E. Shaw & Co
New York
|
$16.9M |
4 |
4
BlackRock
New York
|
$65.4M |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$12.3M |